Keyphrases
Chronic Kidney Disease
100%
Chronic Kidney Disease Patients
72%
Hemodialysis
52%
Oxidative Stress
41%
Gene Polymorphism
30%
Cardiovascular Mortality Risk
29%
Surabaya
29%
Asymmetric Dimethylarginine
28%
Hypertension
26%
Cardiovascular Mortality
25%
End-stage Renal Disease
24%
Hemodialysis Patients
23%
COVID-19
23%
Antihypertensive Drugs
22%
Retrospective Cohort Study
22%
Referral Hospital
22%
Critically Ill COVID-19 Patients
22%
Disease Progression
22%
Non-dialysis Chronic Kidney Disease
21%
Mortality Rate
19%
Mortality Prediction
19%
Cardiovascular Risk
19%
Atherosclerotic Cardiovascular Disease (ASCVD)
18%
High-sensitivity C-reactive Protein (hs-CRP)
18%
Inflammation
18%
Hypertensive
18%
Length of Stay
18%
Risk Factors
17%
Chronic Kidney Disease Stage
17%
Systematic Meta-analysis
16%
Meta-analysis
16%
Indonesian
16%
Maintenance Hemodialysis Patients
15%
8-hydroxydeoxyguanosine (8-OHdG)
15%
Angiotensin-converting Enzyme Inhibitor (ACEi)
14%
Carotid-femoral Pulse Wave Velocity (cfPWV)
14%
N-acetylcysteine
14%
Sarcopenia
14%
Insulin Resistance
14%
Elderly Patients
14%
Dialysate
14%
Angiotensin-converting Enzyme
14%
Interleukin-6 Levels
14%
2 Receptor
14%
Universitas
13%
Single nucleotide Polymorphism
13%
End-stage Renal Disease Patients
12%
Total Antioxidant Capacity
11%
Polymorphism
11%
No Significant Difference
11%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
84%
Hemodialysis
64%
End Stage Renal Disease
31%
Hypertension
29%
Antihypertensive Agent
22%
Cohort Study
22%
Disease Exacerbation
22%
N(g),n(g) Dimethylarginine
22%
6 N,n' Dimethylarginine
22%
Diseases
20%
C Reactive Protein
19%
Receptor
17%
Cross-Sectional Study
16%
Inflammation
16%
Mortality Rate
15%
Creatinine
15%
Sarcopenia
14%
Insulin Resistance
14%
Acetylcysteine
14%
Acute Kidney Failure
14%
Cardiovascular Mortality
14%
Cardiovascular Disease
13%
Antioxidant Capacity
13%
Cardiovascular Risk
12%
Infection
12%
Coronary Artery Atherosclerosis
11%
Homocysteine
10%
Malonaldehyde
10%
Beta Adrenergic Receptor Blocking Agent
8%
8 Hydroxydeoxyguanosine
8%
Thiol
8%
Dicarbonate
7%
Peritoneal Fibrosis
7%
Myostatin
7%
Inotropic Agent
7%
Microflora
7%
Nitric Oxide
7%
Albuminuria
7%
Dexamethasone
7%
Interleukin 6
7%
Immunosuppressive Agent
7%
Iron Poisoning
7%
Chelating Agent
7%
Somatomedin C
7%
Coronavirinae
7%
Neoplasm
7%
Dengue Shock Syndrome
7%
Hydroxychloroquine
7%
Hypotension
7%
Lopinavir Plus Ritonavir
7%
Medicine and Dentistry
Chronic Kidney Disease
69%
Hemodialysis
33%
N(g),n(g) Dimethylarginine
22%
Systematic Review
22%
Meta-Analysis
16%
Oxidative Stress
15%
COVID-19
14%
Acute Kidney Injury
14%
Sarcopenia
14%
Insulin Resistance
14%
Elderly Patient
14%
Cardiovascular Mortality
14%
DNA Polymorphism
14%
Cardiovascular Disease
12%
Infection
12%
Cross Sectional Study
11%
Lymphocyte
11%
Creatinine
10%
Diseases
8%
C Reactive Protein
8%
Diastolic Blood Pressure
8%
End Stage Renal Disease
8%
Cardiovascular Risk
8%
Arterial Stiffness
7%
Low Drug Dose
7%
Neurogenic Bladder
7%
Vesicoureteral Reflux
7%
Hydroxychloroquine
7%
Lopinavir/Ritonavir
7%
Peritoneal Fibrosis
7%
Acetic Acid
7%
Beta Thalassemia
7%
Iron Overload
7%
Hypertension
7%
Albuminuria
7%
Dialysis Fluid
7%
Dengue Shock Syndrome
7%
Drug Megadose
7%
Peritoneal Dialysis
7%
Neoplasm
7%
Sodium Bicarbonate
7%
Hypotension
7%
Sleep Quality
7%
Systemic Lupus Erythematosus
7%
Maturity Onset Diabetes of the Young
7%
Internal Medicine
7%
Lupus Nephritis
7%
Somatomedin C
7%
Myostatin
7%
Receptor
7%